Recombinant Bacillus cereus UPF0751 protein BCE_A0020 (BCE_A0020)

Shipped with Ice Packs
In Stock

Description

Bacillus cereus: An Overview

Bacillus cereus is a Gram-positive, facultatively anaerobic, spore-forming bacterium commonly found in various environments such as soil, vegetation, and diverse food products . It is known for producing toxins that can cause foodborne illnesses, typically resulting in vomiting and diarrhea .

Genetic and Proteomic Insights into Bacillus cereus

  • Genome Sequencing and Analysis: Whole-genome sequencing of Bacillus cereus strains has facilitated the identification of genes and gene clusters involved in the synthesis of toxins and antimicrobial peptides .

  • Antimicrobial Compounds: Research has identified various antimicrobial compounds produced by Bacillus cereus strains, including kurstakin and thumolycin .

  • Enterotoxin Production: Bacillus cereus has a complex regulatory network that links cell wall structure, cell growth, motility, and enterotoxin production .

  • Proteogenomics: Proteomic analyses have identified novel exoproteins in Bacillus cereus, such as EntD, which plays a pivotal role in various cellular processes .

EntD Protein in Bacillus cereus

Proteogenomic analysis of Bacillus cereus ATCC 14579 identified EntD as a novel exoprotein. Disruption of entD impacts cell wall structure, motility, and enterotoxin production .

  • Identification of the entD Gene: Peptide mapping identified the entD gene based on the BC_3716 locus . Sequencing of a PCR product encompassing BC_3716 revealed a frameshift error, and the corrected sequence was deposited in the NCBI database .

  • Transcription Analysis: Transcription analysis showed that the highest expression of entD occurs during the early exponential growth phase .

  • Impact on Cell Wall: Deletion of entD leads to differences in cell wall ultrastructure .

Bacillus cereus and Antimicrobial Activity

Some Bacillus species, including B. subtilis, exhibit broad-spectrum antibacterial activity due to the production of antimicrobial secondary metabolites .

  • Antimicrobial Genes and Compounds: Bacillus strains can encode multiple gene clusters involved in the biosynthesis of antimicrobial secondary metabolites, including non-ribosomal peptides, ribosomal peptides, dipeptides, and polyketides .

  • Examples of Antimicrobial Compounds: Surfactin, fengycin, bacillibactin, bacilysin, and bacillaene are examples of antimicrobial compounds produced by Bacillus species .

Foodborne Outbreaks and Toxin Synthesis

Bacillus cereus strains isolated from foodborne outbreaks have a complex interspecific relationship with B. anthracis and B. thuringiensis . These strains may possess a higher copy number of non-ribosomal polypeptide synthetase (NRPS) genes and carry cereulide synthetase (ces) gene cluster sequences, suggesting their ability to synthesize emetic toxins .

Tables of relevant information

Gene/ProteinDescriptionFunction/Relevance
EntDNovel exoprotein identified in Bacillus cereusImpacts cell wall structure, motility, and enterotoxin production
BC_3716Locus associated with the entD geneUsed for peptide mapping and identification of the entD gene
DeoCDeoxyribose-phosphate aldolaseCatalyzes the conversion of 2-deoxy-D-ribose-5-phosphate into glyceraldehyde-3-phosphate and acetaldehyde
CwlCN-acetylmuramoyl-L-alanine amidaseInvolved in cell wall turnover
SurfactinNon-ribosomal peptideAntimicrobial compound produced by Bacillus species
FengycinNon-ribosomal peptideAntimicrobial compound produced by Bacillus species
BacillibactinNon-ribosomal peptideAntimicrobial compound produced by Bacillus species
BacilysinDipeptideAntimicrobial compound produced by Bacillus species
BacillaenePolyketideAntimicrobial compound produced by Bacillus species
FeatureDescription
Gram-positive bacteriumBacillus cereus is a Gram-positive bacterium, meaning it has a thick peptidoglycan layer in its cell wall that retains the crystal violet stain during Gram staining .
Facultatively anaerobicBacillus cereus is facultatively anaerobic, indicating it can grow in both the presence and absence of oxygen .
Spore-formingBacillus cereus can form spores, which are dormant, highly resistant structures that allow the bacterium to survive under adverse environmental conditions. When conditions become favorable, the spores can germinate and resume vegetative growth .
Toxin-producingBacillus cereus produces toxins that can cause foodborne illnesses. These toxins are generally categorized into two types: emetic toxins (like cereulide) that cause vomiting, and diarrheal toxins that cause diarrhea .
Environmental reservoirsBacillus cereus is commonly found in soil, vegetation, and various food products, including rice, dairy products, and spices . Its ability to form spores contributes to its widespread presence in the environment.
Foodborne illnessesBacillus cereus is a well-known cause of foodborne illnesses. The symptoms and severity of the illness depend on the type and amount of toxin produced in the contaminated food. Emetic toxins typically cause vomiting within 30 minutes to 6 hours after consumption, while diarrheal toxins lead to diarrhea and abdominal pain within 6 to 15 hours .
Regulatory networkBacillus cereus possesses a complex regulatory network that integrates various cellular processes, including cell wall structure, cell growth, motility, and enterotoxin production. This network enables the bacterium to adapt to changing environmental conditions and coordinate the expression of genes involved in virulence and survival .
Antimicrobial potentialSome strains of Bacillus cereus and related Bacillus species have the capacity to produce antimicrobial compounds, such as non-ribosomal peptides (e.g., surfactin, fengycin) and polyketides (e.g., bacillaene). These compounds can inhibit the growth of other microorganisms and contribute to the ecological fitness of the producing strain .
Role in food spoilageBacillus cereus can cause food spoilage due to its ability to produce enzymes that degrade food components, such as proteins and carbohydrates. The bacterium's growth in food products can lead to undesirable changes in texture, flavor, and appearance, reducing the quality and shelf life of the food.
Biocontrol agent potentialCertain Bacillus cereus strains have been explored as biocontrol agents for plant diseases. These strains can produce antimicrobial compounds and other metabolites that suppress plant pathogens, protecting crops from infection. The use of Bacillus cereus as a biocontrol agent represents a sustainable approach to managing plant diseases and reducing the reliance on chemical pesticides .

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your preferred format in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Consult your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, which can serve as a guideline.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The specific tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
BCE_A0020; UPF0751 protein BCE_A0020
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-99
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Bacillus cereus (strain ATCC 10987 / NRS 248)
Target Names
BCE_A0020
Target Protein Sequence
MSTILVLGGS NGRTLEKLAK KRDCQVIFHD GKNHGGVKKT FRSVIKKCDV IVVQKGACGH VSIDVAKEYA KKYDVPLLFN QGFGGTGALE IGLKHLQVA
Uniprot No.

Q&A

How should researchers approach expression and purification of recombinant BCE_A0020?

For successful expression and purification of BCE_A0020, researchers should consider the following methodology:

  • Expression System Selection: Based on success with other B. cereus proteins, E. coli BL21(DE3) is recommended as an initial expression host using vectors like pET28a for His-tag fusion proteins .

  • Optimization Strategy:

    • Express the protein fused with ubiquitin to increase protein yield (as demonstrated with ResD and ResE proteins)

    • Use IPTG at 0.5-1.0 mM for induction

    • Perform induction at lower temperatures (16-25°C) to improve solubility

  • Purification Protocol:

    • Use nickel affinity chromatography for initial purification of His-tagged BCE_A0020

    • Implement size exclusion chromatography as a second purification step

    • Validate purification using SDS-PAGE to confirm electrophoretic homogeneity

This approach has been shown to increase protein yield up to 150 mg per gram of wet cell weight without denaturation steps for other B. cereus proteins .

How can researchers investigate BCE_A0020's potential role in B. cereus pathogenicity?

Investigating the role of BCE_A0020 in pathogenicity requires a multifaceted approach:

  • Construct a Knockout Mutant: Use homologous recombination techniques similar to those employed for entD gene deletion . Specifically:

    • Amplify upstream and downstream regions of BCE_A0020

    • Insert an antibiotic resistance cassette between these regions

    • Transform the construct into B. cereus using natural competence methods

    • Confirm gene deletion via PCR and sequencing

  • Phenotypic Analysis: Compare the mutant strain with wild-type across multiple virulence parameters:

    • Growth kinetics in various media

    • Cellular morphology changes using transmission electron microscopy

    • Motility assays

    • Cytotoxicity on human cell lines (e.g., Caco-2 cells)

    • Hemolytic activity

  • Proteomics Analysis: Conduct comparative proteomics to identify:

    • Changes in cellular proteome

    • Alterations in exoproteome composition

    • Differential expression of known virulence factors (HBL, Nhe, CytK)

What techniques are most effective for analyzing protein-protein interactions involving BCE_A0020?

To effectively characterize BCE_A0020's interactome, researchers should employ complementary approaches:

  • Pull-down Assays:

    • Express His-tagged BCE_A0020 in E. coli

    • Use nickel affinity chromatography to capture the protein and its binding partners

    • Identify interacting proteins via mass spectrometry

  • Bacterial Two-Hybrid System:

    • Construct fusion proteins with BCE_A0020 and potential interaction partners

    • Monitor protein interactions through reporter gene activation

    • Validate positive interactions with alternative methods

  • Fluorescence Microscopy:

    • Create BCE_A0020-SGFP2 fusions similar to those used for SpoVAEa

    • Observe protein localization in live cells

    • Perform co-localization studies with other fluorescently labeled proteins

  • Cross-linking Mass Spectrometry:

    • Utilize chemical cross-linkers to stabilize transient interactions

    • Perform tryptic digestion followed by LC-MS/MS

    • Analyze cross-linked peptides to map interaction interfaces

How can researchers distinguish between genuine BCE_A0020 functions and artifacts in recombinant systems?

The following methodology helps distinguish genuine functions from artifacts:

  • Complementation Analysis:

    • Generate a BCE_A0020 knockout in B. cereus

    • Complement the mutant with wild-type BCE_A0020 and evaluate phenotypic restoration

    • Include proper controls (empty vector, unrelated protein expression)

  • Expression Level Monitoring:

    • Quantify native vs. recombinant expression levels using RT-PCR and western blot

    • Use inducible promoter systems to achieve physiologically relevant expression levels

    • Document changes in phenotype at varying expression levels to establish dose-dependency

  • Cross-Species Validation:

    • Test BCE_A0020 function across different Bacillus species within the B. cereus group

    • Account for genetic background effects as observed with pCER270 plasmid effects on different strains

    • Compare results between closely related species (B. thuringiensis, B. anthracis)

What are the optimal conditions for site-directed mutagenesis studies of BCE_A0020?

Based on successful approaches with other B. cereus proteins, researchers should consider:

  • Key Residue Identification:

    • Perform sequence alignment with homologous proteins

    • Identify conserved amino acids within the UPF0751 family

    • Focus on the characteristic motifs in the protein sequence

  • Mutagenesis Protocol:

    • Use PCR-based site-directed mutagenesis with overlapping primers

    • Target conserved residues in the GGSNGRT and GACGHVS motifs

    • Create alanine substitutions for charge-bearing amino acids (R, K, D, E)

  • Functional Validation Strategy:

    • Express mutant proteins in parallel with wild-type

    • Perform side-by-side biochemical analyses

    • Complement the BCE_A0020 knockout with mutant variants to assess in vivo function

What approaches should be used to determine BCE_A0020's potential involvement in spore formation or germination?

Given the importance of sporulation in B. cereus biology, researchers should examine BCE_A0020's role through:

  • Expression Analysis During Sporulation:

    • Monitor BCE_A0020 expression levels at different stages of sporulation using RT-PCR

    • Create a BCE_A0020-reporter fusion to visualize expression patterns

    • Compare expression in sporulation-deficient mutants vs. wild-type

  • Spore Characteristic Assessment:

    • Compare spore formation efficiency between BCE_A0020 knockout and wild-type strains

    • Evaluate spore heat resistance properties using methods similar to those described for pCER270 studies

    • Measure germination kinetics in response to nutrient germinants like L-alanine and inosine

  • Protein Localization Studies:

    • Create BCE_A0020-fluorescent protein fusions

    • Visualize protein dynamics during sporulation and germination using time-lapse microscopy

    • Determine if BCE_A0020 co-localizes with known sporulation/germination proteins

The table below summarizes key parameters to measure when assessing BCE_A0020's role in sporulation:

ParameterMeasurement MethodExpected Outcome if Involved
Sporulation rateHeat treatment (80°C, 12 min) followed by viable countReduced sporulation in knockout
Spore heat resistanceD-value determination at 90°CAltered D₉₀°C value in knockout
Germination efficiencyOD₆₀₀ decrease in response to germinantsDelayed or reduced germination
Gene expression timingRT-PCR at various sporulation stagesExpression peaks at specific stage
Protein localizationFluorescence microscopyDynamic localization pattern

What statistical approaches are most appropriate for analyzing BCE_A0020 mutant phenotypes?

For robust statistical analysis of BCE_A0020 mutant phenotypes:

  • Appropriate Statistical Tests:

    • Use Student's t-test for comparing two groups (wild-type vs. mutant)

    • Apply ANOVA with post-hoc tests for multiple group comparisons

    • Consider non-parametric alternatives if data doesn't meet normality assumptions

  • Sample Size Determination:

    • Calculate required sample size based on expected effect size

    • Ensure sufficient biological and technical replicates (minimum 3 biological replicates)

    • Consider statistical power analysis to detect meaningful differences

  • Data Visualization:

    • Present results in clear, informative graphs

    • Include individual data points along with means and standard deviations

    • Use consistent scales and formats across related experiments

How can researchers leverage BCE_A0020 studies to understand broader B. cereus group pathogenicity mechanisms?

To extend BCE_A0020 research to broader pathogenicity mechanisms:

  • Comparative Genomics Approach:

    • Examine BCE_A0020 conservation across the B. cereus group

    • Analyze population structure and recombination events that may affect BCE_A0020

    • Identify potential horizontal gene transfer events involving BCE_A0020

  • Integration with Virulence Models:

    • Examine BCE_A0020's potential interaction with known virulence factors

    • Test mutant strains in appropriate infection models

    • Investigate potential involvement in enterotoxin production or secretion

  • Regulatory Network Analysis:

    • Identify potential transcriptional regulators of BCE_A0020

    • Examine if BCE_A0020 affects the expression of virulence genes

    • Construct a regulatory network model including BCE_A0020

What considerations are important when designing BCE_A0020 structural biology experiments?

For structural characterization of BCE_A0020:

  • Protein Production Optimization:

    • Evaluate multiple expression constructs with different fusion tags

    • Test expression in various E. coli strains and conditions

    • Optimize buffer conditions for protein stability

  • Structural Determination Approach:

    • Begin with circular dichroism (CD) spectroscopy for secondary structure estimation

    • Attempt X-ray crystallography with various crystallization conditions

    • Consider NMR for solution structure if protein size permits

    • Use small-angle X-ray scattering (SAXS) for low-resolution envelope determination

  • Structure-Function Analysis:

    • Map conservation patterns onto the determined structure

    • Identify potential functional sites based on structural features

    • Design structure-guided mutagenesis experiments to test functional hypotheses

How can antimicrobial resistance be evaluated in the context of BCE_A0020 studies?

When investigating potential links between BCE_A0020 and antimicrobial resistance:

  • Susceptibility Testing Methodology:

    • Use broth microdilution method rather than disk diffusion, as recommended for B. cereus group isolates

    • Apply CLSI M45 Bacillus spp. breakpoints for interpretation

    • Test a panel of clinically relevant antibiotics

  • Resistance Mechanism Investigation:

    • Determine if BCE_A0020 affects membrane permeability or cell wall structure

    • Examine expression changes in known resistance genes

    • Investigate potential regulatory roles in stress response pathways

  • Genetic Context Analysis:

    • Examine genomic context of BCE_A0020 for proximity to resistance determinants

    • Screen for horizontal gene transfer signatures in the region

    • Look for co-regulation patterns with resistance mechanisms

As demonstrated in B. cereus group studies, antimicrobial resistance gene detection has poor sensitivity and specificity for predicting phenotypic resistance, necessitating careful experimental validation .

What key research questions remain to be addressed regarding BCE_A0020?

Despite advances in Bacillus cereus research, several critical questions about BCE_A0020 remain:

  • What is the precise biological function of BCE_A0020 in B. cereus?

  • Does BCE_A0020 interact with other proteins to form functional complexes?

  • How is BCE_A0020 expression regulated under different environmental conditions?

  • Does BCE_A0020 contribute to virulence, stress resistance, or other adaptive traits?

  • What is the three-dimensional structure of BCE_A0020 and how does it relate to function?

Addressing these questions will require integrated approaches combining genetics, biochemistry, structural biology, and systems biology techniques.

How can researchers effectively collaborate on BCE_A0020 studies across different specialties?

For effective multidisciplinary BCE_A0020 research:

  • Collaborative Framework:

    • Establish clear research objectives and division of responsibilities

    • Ensure standardized experimental protocols across laboratories

    • Implement regular communication channels and data sharing platforms

  • Integrated Experimental Design:

    • Design experiments that leverage complementary expertise

    • Ensure comparable experimental conditions across different aspects of the project

    • Maintain consistent strain and construct repositories

  • Data Management Strategy:

    • Use standardized data formats and annotation schemes

    • Implement robust data sharing and analysis pipelines

    • Plan for integrated publication of results from multiple approaches

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.